Chinese Journal of Pharmaceuticals
|
2025, 56(5): 687-693
• Pharmaceutical Management & Information •
Study on Post-approval Change Management of Medical Devices in the U.S. and Its Implications for China
Full
Xinyue LI
1, 2, Jia CUI
3, Huiqi LI
1, 2, Rong JIANG
1, 2, *
Affiliations
- 1.Institute of Regulatory Sciences, China Pharmaceutical University, Nanjing 211198
- 2.NMPA Key Lab. for Drug Regulatory Innovation and Evaluation, Nanjing 211198
- 3.Center for Food and Drug Inspection of Jiangsu, Nanjing 210008
Published: 2025-05-10
doi: 10.16522/j.cnki.cjph.2025.05.017
Outline
李鑫悦, 崔佳, 李慧琦, 蒋蓉.
美国医疗器械产品上市后变更管理研究及对我国的启示.
中国医药工业杂志,
2025
, 56
(5)
: 687
-693
.
DOI: 10.16522/j.cnki.cjph.2025.05.017
Xinyue LI, Jia CUI, Huiqi LI, Rong JIANG.
Study on Post-approval Change Management of Medical Devices in the U.S. and Its Implications for China[J].
Chinese Journal of Pharmaceuticals,
2025
, 56
(5)
: 687
-693
.
DOI: 10.16522/j.cnki.cjph.2025.05.017
Year 2025 volume 56 Issue 5
39
9
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2025.05.017
- Receive Date:2024-10-13
- Online Date:2026-11-18
- Published:2025-05-10